Inhibiting angiogenesis in breast cancer: the beginning of the end or the end of the beginning?
- PMID: 22331930
- DOI: 10.1200/JCO.2011.38.5492
Inhibiting angiogenesis in breast cancer: the beginning of the end or the end of the beginning?
Comment on
- 
  
  First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.J Clin Oncol. 2012 Mar 20;30(9):921-9. doi: 10.1200/JCO.2011.35.7376. Epub 2012 Feb 13. J Clin Oncol. 2012. PMID: 22331954 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Medical
 
        